Prelude Therapeutics PRLD
NASDAQ PRLD
$3.64 +0.04 (+1.11%)
As of: Oct 23, 2026 · 3:25 PM EDT

Prelude Therapeutics (PRLD) Net Debt Issuances and Repayments (2019 - 2025)

Updated

Analysis

Prelude Therapeutics (PRLD) Net Debt Issuances and Repayments (2019 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Debt Issuance (Qtr)
1 Eli Lilly 1,129.53 Bn 1,098.12 Bn 19.71 Bn 11.58 Bn
2 Johnson & Johnson 635.66 Bn 555.53 Bn 17.30 Bn -4.36 Bn
3 AbbVie 504.81 Bn 477.92 Bn 12.70 Bn -2.00 Bn
4 Merck 358.21 Bn 312.59 Bn 12.21 Bn -5.00 Mn
5 Novartis Ag 290.21 Bn 254.20 Bn 11.24 Bn 2.17 Bn
6 Astrazeneca 264.86 Bn 238.55 Bn 12.86 Bn -2.46 Bn
7 Amgen 237.58 Bn 192.98 Bn 7.24 Bn -
8 Gilead Sciences 194.88 Bn 169.08 Bn 6.22 Bn -17.00 Mn
9 Pfizer 171.14 Bn 117.79 Bn 10.94 Bn 64.00 Mn
10 Prelude Therapeutics 358.13 Mn -239.17 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 -53,000.00
Mar 31, 2025 -155,000.00
Dec 31, 2024 -151,000.00
Sep 30, 2024 -148,000.00
Sep 30, 2020 -67,000.00
Jun 30, 2020 -96,000.00
Mar 31, 2020 -95,000.00
Dec 31, 2019 -93,000.00
API Access

Prelude Therapeutics Net Debt Issuances and Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-debt-issuances-and-repayments&ticker=PRLD&period=max&api_key=YOUR_API_KEY